rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2005-7-5
|
pubmed:abstractText |
There has been little research on the use of human immunodeficiency virus (HIV) postexposure prophylaxis (PEP) for occupational exposure in traveling health care workers (HCWs). Although PEP is the standard of care for occupational exposure to HIV in the United States, in third-world countries such medications are often unavailable and risks to the HCW may be higher. The aims of this study were to assess the incidence and types of blood and body fluid exposure and subsequent use of PEP in traveling HCWs seen at a large travel clinic prior to travel.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1195-1982
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
14-8
|
pubmed:dateRevised |
2009-7-7
|
pubmed:meshHeading |
pubmed-meshheading:15996462-Adult,
pubmed-meshheading:15996462-Anti-HIV Agents,
pubmed-meshheading:15996462-Attitude of Health Personnel,
pubmed-meshheading:15996462-Developing Countries,
pubmed-meshheading:15996462-Environmental Exposure,
pubmed-meshheading:15996462-HIV Infections,
pubmed-meshheading:15996462-Humans,
pubmed-meshheading:15996462-Infectious Disease Transmission, Patient-to-Professional,
pubmed-meshheading:15996462-Medical Staff,
pubmed-meshheading:15996462-Occupational Exposure,
pubmed-meshheading:15996462-Primary Prevention,
pubmed-meshheading:15996462-Questionnaires,
pubmed-meshheading:15996462-Risk Assessment,
pubmed-meshheading:15996462-Travel,
pubmed-meshheading:15996462-United States
|
pubmed:articleTitle |
Postexposure chemoprophylaxis for occupational exposure to human immunodeficiency virus in traveling health care workers.
|
pubmed:affiliation |
Division of Infectious Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.
|
pubmed:publicationType |
Journal Article
|